Washington, April 3 – The United States will impose tariffs of up to 100% on imported patented pharmaceuticals, with President Donald Trump citing national security risks and heavy reliance on foreign supply chains.In a proclamation issued on Thursday, Trump said that “pharmaceuticals and...
active pharmaceutical ingredients
china
drug pricing
healthcare
import restrictions
india
manufacturing
national security
patentdrugs
pharmaceuticals
section 232
supply chains
tariffs
trade agreements
trade policy
united states